1药网 (YI, Financial), a key player in China's healthcare ecosystem, recently experienced a significant stock price drop of 5.46%, trading at $0.612 per share. The trading volume reached 239,676 shares with a turnover rate of 0.28% and a price fluctuation of 8.44%.
The company's latest financial report shows an operating revenue of $502 million, a net loss of $2.39 million, and earnings per share of -$0.03. The gross profit stood at $29.38 million, with a price-to-earnings ratio of -1.44. Currently, there are no institutional ratings for buying, holding, or selling the stock.
In the broader medical sales industry, the overall increase was 0.75%. Notable gainers include 欧麦斯-麦能医疗, Edap Tms S.A., and Henry Schein Services. Meanwhile, companies like Patterson, Cosmos Health Inc., and Henry Schein Services showed high activity levels with turnover rates of 1.56%, 0.62%, and 0.59%, respectively. The stocks with the most significant price fluctuations include Akso Health Group, 1药网, and Synergy Chc Corp., with fluctuations of 12.70%, 9.70%, and 6.15%.
1药网 operates an integrated online and offline platform in China's healthcare sector. It engages in the sale of healthcare products through online and offline retail and wholesale pharmacies. The company also offers value-added services such as online consultations and e-prescription services in China. The business is divided into B2C and B2B segments, with the majority of revenue coming from the B2B segment.
